Nov. 4, 2020 未分類 The 5th Opinion Exchange Meeting on the Forefront of Industry-Government-Academia Cancer Genome Medicine was held.
Oct. 6, 2020 未分類 Research paper by the research group led by Dr. Yoshino, chairman of 22CEMIT, was published in "Nature Medicine".
June 24, 2020 未分類 Dr.Yoshino, chairman of 22CEMIT, has started the world's largest investigator-initiated trial.
May 21, 2020 未分類 Interview featuring Dr.Yoshino, chairman of 22CEMIT, has been published in Microsoft's medical website.
Apr. 20, 2020 未分類 Interview featuring Dr. Yoshino, chairman of 22CEMIT, has been published in BEST DOCTORS IN JAPAN.
Dec. 6, 2019 未分類 The technology developed by Natera Inc "To judge the possibility of cancer recurrence at 90% accuracy" has been invterviewd by TV Asahi Corporation.
July 24, 2019 未分類 Dr. Kentaro Yamazaki, director of 22CEMIT, has received the Annals of Oncology Award 2019.
June 15, 2019 未分類 22CEMIT cooperated in publishing “Handbook of Hereditary Cancer” (published from KANEHARA & CO., LTD. )
Apr. 9, 2019 未分類 22CEMIT Chairman & CEO, Takayuki Yoshino, spoke at Google Cloud Next ’19 | San Francisco on “Virtual Sequencing”.